Advent Bioservices vs Exothera: CDMO Comparison

How does Advent Bioservices compare to Exothera?

As of Jul 2026, Advent Bioservices: no FDA inspections on file, 2 EMA/MHRA GMP certificates. Signal Score 78.1. Exothera: no FDA inspections on file, 4 EMA/MHRA GMP certificates. Signal Score 78.1. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of Advent Bioservices and Exothera on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

London, United Kingdom
Signal Score
78/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
2
Clinical programs (matched)
0
Capacity
—
Modalities
AAV, Lentiviral, Adenoviral
Jumet, BE
Signal Score
78/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
4
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
—
Modalities
AAV, Adenoviral, Lentiviral

Key differences

  • Exothera holds 4 active EMA GMP certificates; Advent Bioservices does not appear in EudraGMDP.
  • Advent Bioservices maintains 2 MHRA / UK GMP certificates; Exothera does not.

Across the cross-modality scorecard, Advent Bioservices carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: Advent Bioservices vs Exothera

How does Advent Bioservices compare to Exothera?

On CDMO Signal's composite Signal Score, Advent Bioservices is 78/100 and Exothera is 78/100; European coverage is 2 active EMA+MHRA certificates for Advent Bioservices vs 4 for Exothera. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

How do Advent Bioservices and Exothera compare on European GMP coverage?

Advent Bioservices holds 0 active EMA GMP certificates and 2 MHRA / UK certificates. Exothera holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

What does the Signal Score gap mean in practice?

Advent Bioservices carries a Signal Score of 78/100 and Exothera carries 78/100 — essentially tied for Exothera. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Advent Bioservices and Exothera for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.